Position in NBIX
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$3,320,238
+$724,960 QoQ
Shares Held
19,700
0.0% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#252
of 772 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Erste Asset Management GmbH holds $19,400,632 across 6 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (17.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
28,831 | $15,621,500 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
This page
|
19,700 | $3,320,238 | |
| 3 | BCRX |
Biocryst Pharmaceuticals Inc
|
40,000 | $400,000 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
3,674 | $58,894 | |
| 5 | RDY |
Dr Reddys Laboratories Ltd
|
0 | $0 | |
| 6 | ZTS |
Zoetis Inc.
|
0 | $0 |
All Filings in NBIX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,320,238 | 19,700 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $2,595,278 | 19,700 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $2,794,051 | 19,700 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $3,341,044 | 23,800 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $3,355,923 | 26,700 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,632,280 | 23,800 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $3,248,700 | 23,800 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $2,742,236 | 23,800 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,276,546 | 23,800 | Shares | Sole | 2024-11-26 | |
| 2024-03-31 | $3,282,496 | 23,800 | Shares | Sole | 2024-11-26 | |
| 2023-12-31 | $3,135,888 | 23,800 | Shares | Sole | 2024-11-26 | |
| 2023-09-30 | $2,677,500 | 23,800 | Shares | Sole | 2024-11-26 | |
| 2023-06-30 | $2,244,340 | 23,800 | Shares | Sole | 2024-11-26 | |
| 2023-03-31 | $2,409,036 | 23,800 | Shares | Sole | 2024-11-26 | |
| 2022-12-31 | $2,842,672 | 23,800 | Shares | Sole | 2024-11-26 | |
| 2022-09-30 | $2,527,798 | 23,800 | Shares | Sole | 2024-11-26 | |
| 2022-06-30 | $2,320,024 | 23,800 | Shares | Sole | 2024-11-26 | |
| 2022-03-31 | $2,231,250 | 23,800 | Shares | Sole | 2024-11-25 | |
| 2021-12-31 | $2,120,733 | 24,900 | Shares | Sole | 2024-11-25 | |
| 2021-09-30 | $2,388,159 | 24,900 | Shares | Sole | 2024-11-25 | |
| 2021-06-30 | $2,423,268 | 24,900 | Shares | Sole | 2024-11-25 | |
| 2021-03-31 | $2,421,525 | 24,900 | Shares | Sole | 2024-11-25 | |
| 2020-12-31 | $2,386,665 | 24,900 | Shares | Sole | 2024-11-25 | |
| 2020-09-30 | $3,817,552 | 39,700 | Shares | Sole | 2024-11-25 | |
| 2020-06-30 | $4,843,400 | 39,700 | Shares | Sole | 2024-11-22 | |
| 2020-03-31 | $3,436,035 | 39,700 | Shares | Sole | 2024-11-22 | |
| No filing history on record for this holder in this stock. | ||||||